Memorial Sloan Kettering Cancer Center has been granted a patent for compounds that may treat or prevent protozoan infections, including Chagas disease, malaria, and sleeping sickness. The patent includes pharmaceutical compositions, kits, and methods related to these compounds. GlobalData’s report on Memorial Sloan Kettering Cancer Center gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Memorial Sloan Kettering Cancer Center, was a key innovation area identified from patents. Memorial Sloan Kettering Cancer Center's grant share as of July 2024 was 37%. Grant share is based on the ratio of number of grants to total number of patents.
Compounds for treating protozoan infections and related diseases
The granted patent US12071436B2 encompasses a series of claims related to specific chemical compounds, particularly those represented by Formula (I') and its derivatives. The claims detail various structural configurations of these compounds, including specific variations denoted as Formula (I'-A), (I'-B), and (I'-C). Additionally, the claims specify conditions regarding substituents, such as R1, R2, R3, and R4, which can take on various chemical forms, including hydrogen and alkyl groups. The patent also covers pharmaceutically acceptable salts of these compounds, indicating their potential utility in pharmaceutical applications.
Furthermore, the patent outlines a pharmaceutical composition that includes the compounds of claim 1 along with a pharmaceutically acceptable excipient. A significant aspect of the patent is its application in treating parasitic infectious diseases, as it describes a method for administering an effective amount of the claimed compounds to subjects in need. The claims provide a comprehensive framework for the development of therapeutic agents targeting parasitic infections, highlighting the versatility and potential efficacy of the compounds described.
To know more about GlobalData’s detailed insights on Memorial Sloan Kettering Cancer Center, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
